Free Trial

Phio Pharmaceuticals (PHIO) SEC Filings & 10K Form

Phio Pharmaceuticals logo
$2.43 -0.05 (-1.85%)
As of 07/3/2025 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Phio Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/25/2025
7:46 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:30 PM
Carson Lisa Cabott (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2025
6:49 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
3:59 PM
Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:00 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:43 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
8:04 AM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
7:20 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:42 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
2:02 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:09 PM
CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/28/2025
11:15 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
3:16 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
2:45 PM
Orca Capital AG (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
01/21/2025
3:39 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
3:44 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
01/17/2025
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/15/2025
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/14/2025
4:18 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
12:34 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/13/2025
9:55 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:06 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/27/2024
4:05 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/26/2024
1:19 PM
CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/23/2024
3:05 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
12/20/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
12/19/2024
7:38 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
10:20 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
9:21 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
1:59 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
1:59 PM
Freeman Jonathan E (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
2:00 PM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:10 PM
BRADFORD PATRICIA A (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
Lockshin Curtis (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:14 PM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:45 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
8:05 AM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B3
08/01/2024
11:15 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form EFFECT
08/01/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
07/26/2024
3:30 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/24/2024
3:30 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:30 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
7:01 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHIO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners